SLOW FLUORIDE OSTEOPOROSIS TREATMENT IS MORE EFFECTIVE FOR MILD-TO-MODERATE BONE LOSS SUBGROUPS, UT SOUTHWESTERN RESEARCHERS TELL FDA ADVISORY COMMITTEE
Executive Summary
University of Texas Southwestern Medical Center's Slow Fluoride slow-release sodium fluoride is more effective at strengthening bone in patients who have mild-to-moderate bone loss than in those who have severe bone loss, UT Southwestern researcher Joseph Zerwekh, PhD, told FDA's Endocrinologic & Metabolic Drugs Advisory Committee Nov. 17.